Dr. Scott McMahon Appointed Medical Director of MoldCo to Combat Mold Toxicity

Dr. Scott McMahon Appointed Medical Director of MoldCo

Mold toxicity is a lurking epidemic, quietly affecting millions of people, yet it often goes unnoticed within the healthcare system. To combat this growing issue, MoldCo, the first digital health platform specifically dedicated to treating mold toxicity, has announced the appointment of Dr. Scott McMahon as its Medical Director. With his extensive background and expertise in mold-related illnesses, particularly Chronic Inflammatory Response Syndrome (CIRS), Dr. McMahon is set to lead a transformative mission in addressing this neglected health crisis.

CIRS is a debilitating condition that results from exposure to mold and water-damaged environments. The symptoms can be wide-ranging and severely impact quality of life but are frequently misdiagnosed, leading patients to face undue hardships. Each year, countless individuals are left in the dark regarding their health challenges, often experiencing symptoms without receiving proper diagnoses or suitable treatments. This is where MoldCo, under Dr. McMahon's guidance, aims to deliver much-needed solutions.

"I’m honored to join MoldCo and scale the work I’ve been doing for years, which is educating patients about mold-related illnesses and providing treatment," Dr. McMahon expressed. "It’s about giving patients answers, especially when traditional medicine often leaves them searching for explanations." His commitment is evident; he has treated over 2,000 CIRS patients across 48 states and 21 countries, making him one of the foremost authorities in the field.

With over three decades in medical practice, Dr. McMahon is a board-certified pediatrician and hospitalist known for his contributions to mold research and public health advocacy. He has co-authored pivotal works, including The Art and Science of CIRS Medicine, alongside Dr. Ritchie Shoemaker, the physician who initially defined CIRS. His extensive experience as a medical witness in mold litigation spans numerous jurisdictions, including ten states and beyond.

Dr. McMahon's involvement with MoldCo comes as a beacon of hope for many who suffer from the effects of mold exposure. Recognizing the urgent need for accessible care, MoldCo was founded by venture investor Ariana Thacker, who herself faced the debilitating impacts of mold toxicity. "Millions live in environments contaminated with mold, unaware of the harm it’s causing them. With Dr. McMahon’s leadership, we are poised to provide world-class care that can truly make a difference," Thacker stated.

MoldCo leverages technology to offer online access to lab testing, expert consultations, and evidence-based treatment protocols. This innovative approach not only strips away the complexities and high costs associated with conventional medicine but also ensures comprehensive care from the comfort of one’s home. Patients can now expect this high standard of care to be available nationwide by the end of 2025, as MoldCo accepts new patients through its website.

Moreover, Dr. McMahon also hosts the distinctive podcast, Medicine and Miracles, where he delves into the intricate relationship between science and spirituality in healing from mold toxicity. Recent episodes feature MoldCo's CEO, Ariana Thacker, narrating her own journey from patient to pioneer in the field, showcasing the profound personal impact behind the initiative.

As MoldCo progresses towards its goals, the combination of expert knowledge, practical solutions, and patient-centric care positions it as a formidable force in the fight against mold toxicity. Working closely with Dr. McMahon, MoldCo is anticipated to revolutionize how mold-related health challenges are identified and treated, ultimately serving the millions affected by this under-recognized illness.

For more information on MoldCo and to access their services, visit moldco.com.